# Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone

> **NCT00577408** · PHASE3 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 60 (actual)

## Conditions studied

- Opiate Dependence
- Heroin Dependence

## Interventions

- **DRUG:** depot naltrexone
- **DRUG:** Oral Naltrexone

## Key facts

- **NCT ID:** NCT00577408
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00577408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00577408, "Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00577408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*